A scientist receives a yearly grant from a pharmaceutical company that funds research on a new cancer drug. After conducting the research, the scientist learns that the new cancer drug is a less effective when compared to many other cancer drugs in the market. After the scientist shares this information with the company, they encourage him to "reanalyze the data" in order to find different results favorable to the pharmaceutical company. The company also suggests that if different results are not found they will withdraw all research funding from the scientist. Which of the following is the scientist facing?

A scientist receives a yearly grant from a pharmaceutical company that funds research on a new cancer drug. After conducting the research, the scientist learns that the new cancer drug is a less effective when compared to many other cancer drugs in the market. After the scientist shares this information with the company, they encourage him to "reanalyze the data" in order to find different results favorable to the pharmaceutical company. The company also suggests that if different results are not found they will withdraw all research funding from the scientist. Which of the following is the scientist facing?



a.

A conflict of interest

b.

A trade secret violation

c.

A privacy violation

d.

A Whistle-blowing allegation



Answer: A


Learn More :

Marketing

Learn More Multiple Choice Question :